Oragenics Stock Analysis
| OGEN Stock | USD 1.38 0.06 4.55% |
Oragenics is overvalued with Real Value of 1.15 and Hype Value of 1.11. The main objective of Oragenics stock analysis is to determine its intrinsic value, which is an estimate of what Oragenics is worth, separate from its market price. There are two main types of Oragenics' stock analysis: fundamental analysis and technical analysis.
The Oragenics stock is traded in the USA on NYSE MKT Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Oragenics is usually not traded on Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day. Oragenics Stock trading window is adjusted to America/New York timezone.
Oragenics | Build AI portfolio with Oragenics Stock |
Oragenics Stock Analysis Notes
The company recorded a loss per share of 30.6. Oragenics last dividend was issued on the 22nd of January 2018. The entity had 1:30 split on the 3rd of June 2025. Oragenics, Inc. develops antibiotics for infectious diseases in the United States. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida. Oragenics operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 5 people. To find out more about Oragenics contact Kimberly Murphy at 813 286 7900 or learn more at https://www.oragenics.com.Oragenics Investment Alerts
| Oragenics generated a negative expected return over the last 90 days | |
| Oragenics has high historical volatility and very poor performance | |
| Oragenics may become a speculative penny stock | |
| Net Loss for the year was (10.57 M) with loss before overhead, payroll, taxes, and interest of (3.79 M). | |
| Oragenics currently holds about 17.87 M in cash with (8.6 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.15. | |
| Oragenics has a poor financial position based on the latest SEC disclosures |
Oragenics Upcoming and Recent Events
Earnings reports are used by Oragenics to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 17th of April 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Oragenics Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.09 M.Technical Drivers
As of the 23rd of July, Oragenics holds the Coefficient Of Variation of (835.25), variance of 137.81, and Risk Adjusted Performance of (0.1). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Oragenics, as well as the relationship between them.Oragenics Price Movement Analysis
The output start index for this execution was eight with a total number of output elements of fifty-three. The Simple Moving Average indicator is calculated by adding the closing price of Oragenics for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Oragenics short-term fluctuations and highlight longer-term trends or cycles.
Oragenics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Oragenics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Oragenics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Oragenics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Oragenics Outstanding Bonds
Oragenics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Oragenics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Oragenics bonds can be classified according to their maturity, which is the date when Oragenics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US68404LAA08 Corp BondUS68404LAA08 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Oragenics Predictive Daily Indicators
Oragenics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Oragenics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Oragenics Forecast Models
Oragenics' time-series forecasting models are one of many Oragenics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Oragenics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Oragenics Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Oragenics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Oragenics shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Oragenics. By using and applying Oragenics Stock analysis, traders can create a robust methodology for identifying Oragenics entry and exit points for their positions.
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida. Oragenics operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 5 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Oragenics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
| All Next | Launch Module |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oragenics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Oragenics Stock, please use our How to Invest in Oragenics guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oragenics. If investors know Oragenics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oragenics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Oragenics is measured differently than its book value, which is the value of Oragenics that is recorded on the company's balance sheet. Investors also form their own opinion of Oragenics' value that differs from its market value or its book value, called intrinsic value, which is Oragenics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oragenics' market value can be influenced by many factors that don't directly affect Oragenics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oragenics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Oragenics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oragenics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.